1. Home
  2. CADL vs SIGIP Comparison

CADL vs SIGIP Comparison

Compare CADL & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
  • SIGIP
  • Stock Information
  • Founded
  • CADL 1999
  • SIGIP N/A
  • Country
  • CADL United States
  • SIGIP United States
  • Employees
  • CADL N/A
  • SIGIP 2800
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • SIGIP Property-Casualty Insurers
  • Sector
  • CADL Health Care
  • SIGIP Finance
  • Exchange
  • CADL Nasdaq
  • SIGIP Nasdaq
  • Market Cap
  • CADL 234.8M
  • SIGIP N/A
  • IPO Year
  • CADL 2021
  • SIGIP N/A
  • Fundamental
  • Price
  • CADL $4.99
  • SIGIP $16.92
  • Analyst Decision
  • CADL Strong Buy
  • SIGIP
  • Analyst Count
  • CADL 5
  • SIGIP 0
  • Target Price
  • CADL $21.40
  • SIGIP N/A
  • AVG Volume (30 Days)
  • CADL 914.4K
  • SIGIP N/A
  • Earning Date
  • CADL 08-12-2025
  • SIGIP N/A
  • Dividend Yield
  • CADL N/A
  • SIGIP N/A
  • EPS Growth
  • CADL N/A
  • SIGIP N/A
  • EPS
  • CADL N/A
  • SIGIP N/A
  • Revenue
  • CADL N/A
  • SIGIP N/A
  • Revenue This Year
  • CADL N/A
  • SIGIP N/A
  • Revenue Next Year
  • CADL N/A
  • SIGIP N/A
  • P/E Ratio
  • CADL N/A
  • SIGIP N/A
  • Revenue Growth
  • CADL N/A
  • SIGIP N/A
  • 52 Week Low
  • CADL $3.79
  • SIGIP N/A
  • 52 Week High
  • CADL $14.60
  • SIGIP N/A
  • Technical
  • Relative Strength Index (RSI)
  • CADL 45.92
  • SIGIP 50.58
  • Support Level
  • CADL $4.73
  • SIGIP $16.61
  • Resistance Level
  • CADL $5.24
  • SIGIP $17.06
  • Average True Range (ATR)
  • CADL 0.29
  • SIGIP 0.13
  • MACD
  • CADL -0.01
  • SIGIP 0.03
  • Stochastic Oscillator
  • CADL 46.36
  • SIGIP 64.58

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.

Share on Social Networks: